Effect of relaxin on TGF-β1 expression in cultured vaginal fibroblasts from women with stress urinary incontinence

Reproductive Sciences

Volumn 15, Issue 3, 2008, Pages 312-320

  Wen, Yan ^a   Zhao, Yang Yu ^a   Polan, Mary Lake ^a   Chen, Bertha ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Extracellular matrix; Fibroblasts; Relaxin; Stress urinary incontinence; TGF 1

Indexed keywords

BINDING PROTEIN; RELAXIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA1 BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL CULTURE; CELL ISOLATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRESS INCONTINENCE; SUPERNATANT; VAGINA; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; CELLS, CULTURED; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; FIBROBLASTS; HUMANS; LATENT TGF-BETA BINDING PROTEINS; MENSTRUAL CYCLE; MIDDLE AGED; PILOT PROJECTS; RELAXIN; TRANSFORMING GROWTH FACTOR BETA1; URINARY INCONTINENCE, STRESS; VAGINA;

EID: 42249088881     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719108315299     Document Type: Article

References (44)

1. Rohr G., Stovring H., Christensen K., Gaist D., Nybo H., Kragstrup J. Characteristics of middle-aged and elderly women with urinary incontinence. Scand J Prim Health Care. 2005 ; 23: 203-208.
2. Beck RP, Hsu N. Pregnancy, childbirth, and the menopause related to the development of stress incontinence. Am J Obstet Gynecol. 1965 ; 91: 820-823.
3. Howard D., Delancey JO, Tunn R., Ashton-Miller JA Racial differences in the structure and function of the stress urinary continence mechanism. Obstet Gynecol. 2000 ; 95: 713-717.
4. Sampselle CM, Harlow SD, Skurnick J., Brubaker L., Bondarenko I. Urinary incontinence predictors and life impact in ethnically diverse perimenopausal women. Obstet Gynecol. 2002 ; 100: 1230-1238.
5. Delancey JO, Ashton-Miller JA Pathophysiology of adult urinary incontinence. Gastroenterology. 2004 ; 126: S23 - S32.
6. Lin AS, Carrier S., Morgan DM, Lue TF Effect of simulated birth trauma on the urinary continence mechanism in the rat. Urology. 1998 ; 52: 143-151.
7. Taipale J., Keski-Oja J. Growth factors in the extracellular matrix. FASEB J. 1997 ; 11: 51-59.
8. McGowan SE, McNamer R. Transforming growth factor-beta increases elastin production by neonatal rat lung fibroblasts. Am J Respir Cell Mol Biol. 1990 ; 3: 369-376.
9. Gleizes PE, Munger JS, Nunes I., et al. TGF-beta latency: biological significance and mechanisms of activation. Stem Cells. 1997 ; 15: 190-197.
10. Overall CM, Wrana JL, Sodek J. Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts: comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. J Biol Chem. 1991 ; 266: 14064-14071.
11. Taipale J., Saharinen J., Keski-Oja J. Extracellular matrix-associated transforming growth factor-beta: role in cancer cell growth and invasion. Adv Cancer Res. 1998 ; 75: 87-134.
12. Bonewald LF Regulation and regulatory activities of transforming growth factor beta. Crit Rev Eukaryot Gene Expr. 1999 ; 9: 33-44.
13. Annes JP, Munger JS, Rifkin DB Making sense of latent TGFbeta activation. J Cell Sci. 2003 ; 116: 217-224.
14. Jackson SR, Avery NC, Tarlton JF, Eckford SD, Abrams P., Bailey AJ Changes in metabolism of collagen in genitourinary prolapse. Lancet. 1996 ; 347: 1658-1661.
15. Yamamoto K., Yamamoto M., Akazawa K., Tajima S., Wakimoto H., Aoyagi M. Decrease in elastin gene expression and protein synthesis in fibroblasts derived from cardinal ligaments of patients with prolapsus uteri. Cell Biol Int. 1997 ; 21: 605-611.
16. Chen BH, Wen Y., Li H., Polan ML Collagen metabolism and turnover in women with stress urinary incontinence and pelvic prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2002 ; 13: 80-87.
17. Chen B., Wen Y., Polan ML Elastolytic activity in women with stress urinary incontinence and pelvic organ prolapse. Neurourol Urodyn. 2004 ; 23: 119-126.
18. Chen B., Wen Y., Yu X., Polan ML The role of neutrophil elastase in elastin metabolism of pelvic tissues from women with stress urinary incontinence. Neurourol Urodyn. 2007 ; 26: 274-279.
19. Samuel CS Relaxin: antifibrotic properties and effects in models of disease. Clin Med Res. 2005 ; 3: 241-249.
20. Unemori EN, Amento EP Relaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblasts. J Biol Chem. 1990 ; 265: 10681-10685.
21. Unemori EN, Pickford LB, Salles AL, et al. Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo. J Clin Invest. 1996 ; 98: 2739-2745.
22. Mookerjee I., Unemori EN, Du XJ, Tregear GW, Samuel CS Relaxin modulates fibroblast function, collagen production, and matrix metalloproteinase-2 expression by cardiac fibroblasts. Ann N Y Acad Sci. 2005 ; 1041: 190-193.
23. Samuel CS, Mookerjee I., Masterson R., Tregear GW, Hewitson TD Relaxin regulates collagen overproduction associated with experimental progressive renal fibrosis. Ann N Y Acad Sci. 2005 ; 1041: 182-184.
24. Seibold JR, Korn JH, Simms R., et al. Recombinant human relaxin in the treatment of scleroderma: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2000 ; 132: 871-879.
25. Palejwala S., Stein DE, Weiss G., Monia BP, Tortoriello D., Goldsmith LT Relaxin positively regulates matrix metalloproteinase expression in human lower uterine segment fibroblasts using a tyrosine kinase signaling pathway. Endocrinology. 2001 ; 142: 3405-3413.
26. Chen B., Wen Y., Yu X., Polan ML Elastin metabolism in pelvic tissues: is it modulated by reproductive hormones ? Am J Obstet Gynecol. 2005 ; 192: 1605-1613.
27. Pedrozo HA, Schwartz Z., Robinson M., et al. Potential mechanisms for the plasmin-mediated release and activation of latent transforming growth factor-beta1 from the extracellular matrix of growth plate chondrocytes. Endocrinology. 1999 ; 140: 5806-5816.
28. Taipale J., Koli K., Keski-Oja J. Release of transforming growth factor-beta 1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin. J Biol Chem. 1992 ; 267: 25378-25384.
29. Taipale J., Miyazono K., Heldin CH, Keski-Oja J. Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein. J Cell Biol. 1994 ; 124: 171-181.
30. Rortveit G., Daltveit AK, Hannestad YS, Hunskaar S. Urinary incontinence after vaginal delivery or cesarean section. N Engl J Med. 2003 ; 348: 900-907.
31. Bani D. Relaxin: a pleiotropic hormone. Gen Pharmacol. 1997 ; 28: 13-22.
32. Garber SL, Mirochnik Y., Brecklin CS, et al. Relaxin decreases renal interstitial fibrosis and slows progression of renal disease. Kidney Int. 2001 ; 59: 876-882.
33. Heeg MHJ, Koziolek MJ, Vasko R., et al. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway. Kidney Int. 2005 ; 68: 96-109.
34. Border WA, Noble NA Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994 ; 331: 1286-1292.
35. Blobe GC, Schiemann WP, Lodish HF Role of transforming growth factor beta in human disease. N Engl J Med. 2000 ; 342: 1350-1358.
36. Sato Y., Rifkin DB Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. J Cell Biol. 1989 ; 109: 309-315.
37. Yu Q., Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 2000 ; 14: 163-176.
38. Dallas SL, Miyazono K., Skerry TM, Mundy GR, Bonewald LF Dual role for the latent transforming growth factor-beta binding protein in storage of latent TGF-beta in the extracellular matrix and as a structural matrix protein. J Cell Biol. 1995 ; 131: 539-549.
39. Taipale J., Lohi J., Saarinen J., Kovanen PT, Keski-Oja J. Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells. J Biol Chem. 1995 ; 270: 4689-4696.
40. Dallas SL, Rosser JL, Mundy GR, Bonewald LF Proteolysis of latent transforming growth factor-beta (TGF-beta)-binding protein-1 by osteoclasts: a cellular mechanism for release of TGF-beta from bone matrix. JBiol Chem. 2002 ; 277: 21352-21360.
41. Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell. 1997 ; 91: 439-442.
42. Kafienah W., Buttle DJ, Burnett D., Hollander AP Cleavage of native type I collagen by human neutrophil elastase. Biochem J. 1998 ; 330 (pt 2). 897-902.
43. Lyons RM, Keski-Oja J., Moses HL Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol. 1988 ; 106: 1659-1665.
44. Dixon A., Maric C. 17 β-estradiol attenuates diabetic kidney disease via regulating extracellular matrix and transforming growth factor-beta protein expression and signaling. Am J Physiol Renal Physiol. 2007 ; 293: F1678-1690.